Super-charged NK cells inhibit growth and progression of stem-like/poorly differentiated oral tumors in vivo in humanized BLT mice; effect on tumor differentiation and response to chemotherapeutic drugs

References

• Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. Ca-a Cancer J Clin. 2012;62(1):p. 10–29. doi:10.3322/caac.20138.
   PubMed Web of Science ®Google Scholar
• Gibson MK, Forastiere AA. Reassessment of the role of induction chemotherapy for head and neck cancer. Lancet Oncol. 2006;7(7):p. 565–74. doi:10.1016/S1470-2045(06)70757-4.
   PubMed Web of Science ®Google Scholar
• Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10(6):p. 717–28. doi:10.1016/j.stem.2012.05.007.
   PubMed Web of Science ®Google Scholar
• Yu CC, Tsai LL, Wang ML, Yu CH, Lo WL, Chang YC, Chiou GY, Chou MY, Chiou SH. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res. 2013;73(11):p. 3425–40. doi:10.1158/0008-5472.CAN-12-3840.
   PubMed Web of Science ®Google Scholar
• Chiou, S.H., Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14(13):p. 4085–95. doi:10.1158/1078-0432.CCR-07-4404.
   PubMed Web of Science ®Google Scholar
• Schatton T, Frank MH. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res. 2008;21(1):p. 39–55.
   PubMed Web of Science ®Google Scholar
• Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences. Clin Cancer Res. 2000;6(7):p. 2794–802.
   PubMed Web of Science ®Google Scholar
• Cabrera CM, Nieto A, Cortes JL, Montes RM, Catalina P, Cobo F, Barroso-Del-Jesus A, Concha A. The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level. Cell Biol Int. 2007;31(9):p. 1072–1078. doi:10.1016/j.cellbi.2007.03.015.
   PubMed Web of Science ®Google Scholar
• Uppaluri R, Dunn GP, JS Lewis Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun. 2008;8:p. 16.
   PubMedGoogle Scholar
• Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression. Proc Natl Acad Sci U S A. 1998;95(3):p. 1178–83. doi:10.1073/pnas.95.3.1178.
   PubMed Web of Science ®Google Scholar
• Turkseven MR, Oygur T. Evaluation of natural killer cell defense in oral squamous cell carcinoma. Oral Oncol. 2010;46(5):p. e34–7. doi:10.1016/j.oraloncology.2010.02.019.
   PubMed Web of Science ®Google Scholar
• Accomando WP, Wiencke JK, Houseman EA, Butler RA, Zheng S, Nelson HH, Kelsey KT. Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clin Cancer Res. 2012;18(22):p. 6147–54. doi:10.1158/1078-0432.CCR-12-1008.
   PubMed Web of Science ®Google Scholar
• Mickel RA, Kessler DJ, Taylor JM, Lichtenstein A. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res. 1988;48(17):p. 5017–22.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Jewett A, et al., Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells. Plos One. 2010;5(7):e11590. doi:10.1371/journal.pone.0011590.
   Web of Science ®Google Scholar
• Tseng H-C, Bui V, Man YG, Cacalano N, Jewett A. Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors. Front immunol. 2014;5:p. 269–269. doi:10.3389/fimmu.2014.00269.
   PubMed Web of Science ®Google Scholar
• Jewett A, Man Y-G, Tseng H-C, Dual Functions of Natural Killer Cells in Selection and Differentiation of Stem Cells; Role in Regulation of Inflammation and Regeneration of Tissues. J Cancer. 2013;4(1):p. 12–24. doi:10.7150/jca.5519.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Cacalano N, Jewett A. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget. 2015;6(11):p. 8947–59. doi:10.18632/oncotarget.3250.
   PubMedGoogle Scholar
• Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, Kittipongdaja P, Chen A, Bristol G, Galic Z, et al., A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood. 2010;115(8):p. 1534–44. doi:10.1182/blood-2009-04-215855.
   PubMed Web of Science ®Google Scholar
• Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA. Using the BLT humanized mouse as a stem cell based gene therapy tumor model. J Vis Exp. 2012(70):p. e4181.
   PubMed Web of Science ®Google Scholar
• Brehm C, Huenecke S, Quaiser A, Esser R, Bremm M, Kloess S, Soerensen J, Krevenberg H, Seidl C, Koehl U, et al., IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. PLoS One. 2011;6(11):p. e27351. doi:10.1371/journal.pone.0027351.
   PubMed Web of Science ®Google Scholar
• Venton G, Labiad Y, Colle J, Fino A, Afridi S, Torres M, Monteuil S, Loriod B, Fernandez-Nunez N, Farnault L, et al., Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis. Immunol Res. 2016;64(5-6):p. 1225–1236. doi:10.1007/s12026-016-8848-0.
   PubMed Web of Science ®Google Scholar
• Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, et al., Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):p. 3051–7. doi:10.1182/blood-2004-07-2974.
   PubMed Web of Science ®Google Scholar
• Bachanova V, Burns LJ, McKenna DH, Curtsinger J, Panoskaltsis-Mortari A, Lindgren BR, Cooley S, Weisdorf D, Miller JS. Allogeneic natural killer cells for refractory lymphoma. Cancer Immunol Immunother. 2010;59(11):p. 1739–44. doi:10.1007/s00262-010-0896-z.
   PubMed Web of Science ®Google Scholar
• Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, et al., Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia. Leukemia. 2017;31(5):p. 1108–1116. doi:10.1038/leu.2016.360.
   PubMed Web of Science ®Google Scholar
• Cooley S, Burns LJ, Repka T, Miller JS. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Exp Hematol. 1999;27(10):p. 1533–41. doi:10.1016/S0301-472X(99)00089-2.
   PubMed Web of Science ®Google Scholar
• Kaur K, Cook J, Park SH, Topchyan P, Kozlowska A, Ohanian N, Fang C, Nishimura I, Jewett A. Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients. Front Immunol. 2017;8:p. 297. doi:10.3389/fimmu.2017.00297.
   PubMedGoogle Scholar
• Kozlowska AK, Kaur K, Topchyan P, Jewett A. Novel strategies to target cancer stem cells by NK cells; studies in humanized mice. Front Biosci (Landmark Ed). 2017;22:p. 370–384.
   PubMed Web of Science ®Google Scholar
• Kozlowska AK, Kaur K, Topchyan P, Jewett A. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice. Cancer Immunol Immunother. 2016;65(7):p. 835–45. doi:10.1007/s00262-016-1822-9.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Jewett A, et al., Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells. PLoS One. 2010;5(7):p. e11590. doi:10.1371/journal.pone.0011590.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Bui V, Man YG, Cacalano N, Jewett A. Induction of Split Anergy Conditions Natural Killer Cells to Promote Differentiation of Stem Cells through Cell-Cell Contact and Secreted Factors. Front Immunol. 2014;5:p. 269. doi:10.3389/fimmu.2014.00269.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Cacalano N, Jewett A. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget. 2015;6:8947–8959. doi:10.18632/oncotarget.3250.
   Google Scholar
• Tseng HC, Inagaki A, Bui VT, Cacalano N, Kasahara N, Man YG, Jewett A. Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells. J Cancer. 2015;6(9):p. 866–76. doi:10.7150/jca.11527.
   PubMed Web of Science ®Google Scholar
• Kozlowska AK, Topchyan P, Kaur K, Tseng HC, Teruel A, Hiraga T, Jewett A. Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs. J Cancer. 2017;8(4):p. 537–554. doi:10.7150/jca.15989.
   PubMed Web of Science ®Google Scholar
• Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA. Structural basis of MHC class I recognition by natural killer cell receptors. Immunol Rev. 2001;181:p. 52–65. doi:10.1034/j.1600-065X.2001.1810104.x.
   PubMed Web of Science ®Google Scholar
• Cerwenka A, Lanier LL. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens. 2003;61(5):p. 335–43. doi:10.1034/j.1399-0039.2003.00070.x.
   PubMedGoogle Scholar
• Stroynowski I, Clark S, Henderson LA, Hood L, McMillan M, Forman J. Interaction of alpha 1 with alpha 2 region in class I MHC proteins contributes determinants recognized by antibodies and cytotoxic T cells. J Immunol. 1985;135(3):p. 2160–6.
   PubMed Web of Science ®Google Scholar
• Bui VT, Tseng HC, Kozlowska A, Maung PO, Kaur K, Topchyan P, Jewett A. Augmented IFN-gamma and TNF-alpha Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10. Front Immunol. 2015;6:p. 576. doi:10.3389/fimmu.2015.00576.
   PubMed Web of Science ®Google Scholar
• Pek EA, Chan T, Reid S, Ashkar AA. Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology. 2011;216(1-2):p. 218–24. doi:10.1016/j.imbio.2010.04.008.
   PubMed Web of Science ®Google Scholar
• Jewett A, Bonavida B. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol. 1996;156(3):p. 907–15.
   PubMed Web of Science ®Google Scholar
• Tseng HC, Kanayama K, Kaur K, Park SH, Park S, Kozlowska A, Sun S, McKenna CE, Nishimura I, Jewett A. Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation. Oncotarget. 2015;6(24):p. 20002–25. doi:10.18632/oncotarget.4755.
   PubMedGoogle Scholar
• Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Zack JA, et al., Antitumor activity from antigen-specific CD8T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci U S A. 2011;108(51):p. E1408–16. doi:10.1073/pnas.1115050108.
   PubMed Web of Science ®Google Scholar
• Jewett A, Cavalcanti M, Bonavida B. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol. 1997;159(10):p. 4815–22.
   PubMed Web of Science ®Google Scholar
• Jewett A, Bonavida B. Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells. J Clin Immunol. 1995;15(1):p. 35–44. doi:10.1007/BF01489488.
   PubMed Web of Science ®Google Scholar
• Jewett A, Wang MY, Teruel A, Poupak Z, Bostanian Z, Park NH. Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex class I antigens by nuclear factor kappaB in HEp2 tumor cell line: effect on the function of natural killer cells. Hum Immunol. 2003;64(5):p. 505–20. doi:10.1016/S0198-8859(03)00039-9.
   PubMed Web of Science ®Google Scholar